Pharmaron Beijing Co., Ltd. (SHE:300759)

Market Cap	52.30B
Revenue (ttm)	13.11B
Net Income (ttm)	1.38B
Shares Out	1.77B
EPS (ttm)	0.78
PE Ratio	40.09
Forward PE	27.02
Dividend	0.20 (0.66%)
Ex-Dividend Date	Jul 4, 2025

Volume	45,384,688
Average Volume	50,081,695
Open	29.44
Previous Close	31.34
Day's Range	29.44 - 32.62
52-Week Range	19.15 - 36.42
Beta	0.93
RSI	59.64
Earnings Date	Aug 22, 2025

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 21,370
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300759

Financial Performance

In 2024, Pharmaron Beijing's revenue was 12.28 billion, an increase of 6.39% compared to the previous year's 11.54 billion. Earnings were 1.79 billion, an increase of 12.01%.